The Leukotriene Inhibitors market was valued at USD 2.45 Billion in 2024 and is expected to reach USD 3.97 Billion by 2032, growing at a CAGR of 6.22% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.